genOway SA (ALGEN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Virbac SA

Valneva SE

EUROAPI SA

Transgene SA

Inventiva SA

Acticor Biotech SAS

Pharnext SA

Valbiotis SA

Afyren SAS

Aelis Farma SA

genOway SA

Why is genOway SA ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.48%

EBIT Growth (5y)

11.74%

EBIT to Interest (avg)

-4.83

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.03

Sales to Capital Employed (avg)

0.80

Tax Ratio

41.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

5.25%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.73

EV to EBIT

-26.52

EV to EBITDA

28.62

EV to Capital Employed

1.82

EV to Sales

1.37

PEG Ratio

Dividend Yield

ROCE (Latest)

-6.88%

ROE (Latest)

7.12%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at 0 %

RAW MATERIAL COST(Y)

Fallen by -80.99% (YoY

PRE-TAX PROFIT(Q)

Highest at EUR 0 MM

-6What is not working for the Company

ROCE(HY)

Lowest at 7.5%

CASH AND EQV(HY)

Lowest at EUR 2.12 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

EPS(Q)

Lowest at EUR 0

Here's what is working for genOway SA

Debt-Equity Ratio

Lowest at 0 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit

Highest at EUR 0 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (EUR MM)

Pre-Tax Profit

At EUR 0 MM has Grown at 100%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (EUR MM)

Raw Material Cost

Fallen by -80.99% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for genOway SA

EPS

Lowest at EUR 0

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (EUR)

Cash and Eqv

Lowest at EUR 2.12 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio